Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database

被引:36
作者
Elnair, Radowan [1 ]
Ellithi, Moataz [2 ]
Kallam, Avyakta [1 ]
Shostrom, Valerie [3 ]
Bociek, Robert G. [1 ]
机构
[1] Univ Nebraska Med Ctr, Div Oncol & Hematol, Omaha, NE 68198 USA
[2] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Vermillion, SD USA
[3] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
关键词
Richter's transformation; Richter's syndrome; Diffuse large B-cell lymphoma; Chronic lymphocytic leukemia; B-CELL LYMPHOMA; HODGKIN LYMPHOMA; CLL; TRANSPLANTATION; CLONALITY; BLOOD;
D O I
10.1007/s00277-021-04603-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Richter's transformation (RT) is a rare complication arising in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and is associated with an overall dismal outcome. The rarity of this entity poses many challenges in understanding its biology and outcomes seen and the optimal treatment approach. We utilized the SEER (Surveillance, Epidemiology and End Results) database to identify patients diagnosed with CLL/SLL between 2000 and 2016 and subsequently had a diagnosis of diffuse large B-cell lymphoma (DLBCL) or Hodgkin lymphoma (HL), thus capturing those who experienced an RT event. We compared the outcomes of those patients to those of patients in the database diagnosed with DLBCL without a preceding CLL/SLL diagnosis. We identified 530 patients who developed RT out of 74,116 patients diagnosed with CLL/SLL in the specified period. The median age at RT diagnosis was 66 years, and the median time from CLL/SLL diagnosis to RT development was roughly 4 years. Patients with RT had a dismal outcome with median overall survival of 10 months. We identified advanced Ann Arbor stage (III/IV) and prior treatment for CLL as predictors of worse outcome in patients with RT. Our study represents the largest dataset of patients with CLL/SLL and RT and adds to the existing literature indicating the poor outcomes for those patients.
引用
收藏
页码:2513 / 2519
页数:7
相关论文
共 28 条
[1]   Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].
Abramson, Jeremy S. ;
Palomba, M. Lia ;
Gordon, Leo I. ;
Lunning, Matthew A. ;
Wang, Michael ;
Arnason, Jon ;
Mehta, Amitkumar ;
Purev, Enkhtsetseg ;
Maloney, David G. ;
Andreadis, Charalambos ;
Sehgal, Alison ;
Solomon, Scott R. ;
Ghosh, Nilanjan ;
Albertson, Tina M. ;
Garcia, Jacob ;
Kostic, Ana ;
Mallaney, Mary ;
Ogasawara, Ken ;
Newhall, Kathryn ;
Kim, Yeonhee ;
Li, Daniel ;
Siddiqi, Tanya .
LANCET, 2020, 396 (10254) :839-852
[2]   Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC) [J].
Abrisqueta, Pau ;
Delgado, Julio ;
Alcoceba, Miguel ;
Carla Oliveira, Ana ;
Loscertales, Javier ;
Hernandez-Rivas, Jose A. ;
Ferra, Christelle ;
Cordoba, Raul ;
Yanez, Lucrecia ;
Medina, Angeles ;
Motllo, Cristina ;
Iacoboni, Gloria ;
Villacampa, Guillermo ;
Gonzalez, Marcos ;
Bosch, Francesc .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) :854-863
[3]   Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials [J].
Al-Sawaf, O. ;
Robrecht, S. ;
Bahlo, J. ;
Fink, A. M. ;
Cramer, P. ;
Von Tresckow, J. ;
Lange, E. ;
Kiehl, M. ;
Dreyling, M. ;
Ritgen, M. ;
Duerig, J. ;
Tausch, E. ;
Schneider, C. ;
Stilgenbauer, S. ;
Wendtner, C. M. ;
Fischer, K. ;
Goede, V ;
Hallek, M. ;
Eichhorst, B. .
LEUKEMIA, 2021, 35 (01) :169-176
[4]   Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax [J].
Anderson, Mary Ann ;
Tam, Constantine ;
Lew, Thomas E. ;
Juneja, Surender ;
Juneja, Manu ;
Westerman, David ;
Wall, Meaghan ;
Lade, Stephen ;
Gorelik, Alexandra ;
Huang, David C. S. ;
Seymour, John F. ;
Roberts, Andrew W. .
BLOOD, 2017, 129 (25) :3362-3370
[5]   Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study [J].
Ben-Dali, Yasmin ;
Hleuhel, Mariam H. ;
da Cunha-Bang, Caspar ;
Brieghel, Christian ;
Poulsen, Christian B. ;
Clasen-Linde, Erik ;
Bentzen, Hans H. N. ;
Frederiksen, Henrik ;
Christiansen, Ilse ;
Nielsen, Linda H. ;
Enggaard, Lisbeth ;
Helleberg, Marie ;
Clausen, Michael ;
Frederiksen, Mikael ;
Pedersen, Robert S. ;
Niemann, Carsten U. ;
Andersen, Michael A. .
LEUKEMIA & LYMPHOMA, 2020, 61 (06) :1435-1444
[6]   Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [J].
Cwynarski, Kate ;
van Biezen, Anja ;
de Wreede, Liesbeth ;
Stilgenbauer, Stephan ;
Bunjes, Donald ;
Metzner, Bernd ;
Koza, Vladimir ;
Mohty, Mohamad ;
Remes, Kari ;
Russell, Nigel ;
Nagler, Arnon ;
Scholten, Marijke ;
de Witte, Theo ;
Sureda, Anna ;
Dreger, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2211-2217
[7]  
Davids MS, 2020, J CLIN ONCOL, V38
[8]   Richter's syndrome (RS) in patients with chronic lymphocytic leukemia (CLL) on novel agent therapy. [J].
Davids, Matthew Steven ;
Huang, Ying ;
Rogers, Kerry Anne ;
Stern, Robert ;
Brown, Jennifer R. ;
Thompson, Philip A. ;
Brander, Danielle M. ;
Danilov, Alexey Valeryevich ;
Ujjani, Chaitra Shankar ;
Parikh, Sameer Ashok ;
Barrientos, Jacqueline Claudia ;
Tam, Constantine ;
Woyach, Jennifer Ann .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[9]   Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL) [J].
Griffiths, Robert ;
Gleeson, Michelle ;
Knopf, Kevin ;
Danese, Mark .
BMC CANCER, 2010, 10
[10]   Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib [J].
Hampel, Paul J. ;
Cherng, Hua-Jay J. ;
Call, Timothy G. ;
Ding, Wei ;
Khanlari, Mahsa ;
McPhail, Ellen D. ;
Miranda, Roberto N. ;
Lin, Pei ;
Tawbi, Hussein A. ;
Ferrajoli, Alessandra ;
Wierda, William G. ;
Jain, Nitin ;
Parikh, Sameer A. .
BLOOD ADVANCES, 2020, 4 (18) :4508-4511